Metoprolol Zk Biofarm

Metoprolol, the active ingredient in Metoprolol Zk Biofarm, is a beta‑adrenergic blocker presented as a tablet oral for oral use. It treats hypertension, angina pectoris, myocardial infarction, heart failure and certain cardiac arrhythmias in adult patients.

GNH USA supplies Metoprolol Zk Biofarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol is a selective β1‑blocker used in cardiovascular disease management. It helps control blood pressure and heart workload across several conditions. - Hypertension: lowers systolic and diastolic pressure by reducing heart rate and cardiac output. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Myocardial infarction: improves survival by limiting heart strain after an acute event. - Heart failure: enhances ventricular function and reduces hospitalization risk. - Cardiac arrhythmias: stabilises heart rhythm by slowing conduction through the AV node.

Metoprolol may cause a range of adverse reactions, from mild to severe. Patients should be aware of both common and rare events.

Common Side Effects: - Fatigue - Dizziness or light‑headedness - Bradycardia (slow heart rate) - Cold extremities - Gastrointestinal upset (nausea, abdominal pain) - Headache

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm, especially in asthmatic patients - Acute heart failure exacerbation - Allergic reactions (rash, angioedema) - Depression or mood changes

Before initiating Metoprolol, clinicians should evaluate patient history and monitor for specific risks. - Monitor blood pressure: ensure values are within target range after starting therapy. - Assess cardiac function: watch for signs of worsening heart failure or conduction abnormalities. - Use caution in asthma or chronic obstructive pulmonary disease: β1‑selectivity may not fully prevent bronchospasm. - Avoid abrupt discontinuation: taper dose to prevent rebound tachycardia or hypertension. - Adjust dose in renal impairment: renal clearance may affect drug levels. - Store at room temperature: keep in the original pack, protect from moisture.

Metoprolol can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Verapamil or diltiazem: combined AV‑node blockade may cause severe bradycardia. - Clonidine: abrupt withdrawal of clonidine while on Metoprolol can precipitate hypertensive crisis. - Other β‑blockers: additive cardiac depression may lead to heart block.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce antihypertensive effect. - Diuretics: risk of excessive hypotension or electrolyte imbalance. - Antidepressants (e.g., SSRIs, SNRIs): may increase plasma Metoprolol levels. - Calcium channel blockers (non‑dihydropyridines): require dose adjustment. - Antidiabetic agents: may mask hypoglycaemia symptoms.